A stable GS115 Pichia pastoris recombinant strain was constructed to secrete a truncated form of the human α(1,3/4) fucosyltransferase (amino acids 45-361). Enzyme production resulted from a secretory pathway based on the pre-pro-α mating factor signal sequence of the yeast Saccharomyces cerevisiae. Following its transit through the Golgi apparatus, the enzyme accumulated in the periplasmic space before its release in the culture broth (about 30 mg/l). Cell-enclosed enzyme (∼0.16%) proved to be fairly stable for many freezing and thawing cycles and could be used several times as an immobilized catalyst. Soluble enzyme (>99.8%) representing the main protein of the culture broth (10%) has been characterized by Western-blotting, substrate specificities and kinetic parameters. The two forms (cell-enclosed and soluble) of recombinant enzyme may be used for in vitro synthesis of Lewis a determinants.
Introduction
Synthesis of Lewis a (Le a ), Lewis × (Le x ), sialyl-Lewis a (sLe a ), and sialyl-Lewis x (sLe x ) determinants requires Lewis blood group α(1,3/4) fucosyltransferase (Fuc-TIII) (Kukowska-Latallo et al., 1990) . Fucosylated cell surface glycoconjugates belonging to the Lewis group system have been shown to be physiologically important. Le a and Le b are the major Lewis antigens found on human erythrocytes. The fucosylated glycosphingolipids are synthesized by exocrine epithelial cells (Oriol et al., 1986) and then passively adsorbed onto erythrocytes in the peripheral circulation giving these blood cells their Lewis phenotype (Marcus and Cass, 1969) . The determinant sLe x is found at the surface of leukocytes and tumor cells (Walz et al., 1990) whereas sLe a is mostly found at the surface of cancer cells of the digestive tract (Takada et al., 1991) . The cell surface glycoconjugates are essential for adhesion between leukocytes and vascular endothelium during the inflammatory reaction. During this process, leukocytes interact with E-selectin present at the surface of endothelial cells via sLe x structures Berg et al., 1992; Foxall et al., 1992) . The two determinants have also been shown to be components of ligands for L-and P-selectins (Berg et al., 1992; Foxall et al., 1992) .
Easy and cost-effective means for obtaining large amounts of isolated Fuc-TIII are needed for: (1) its use in chemo-enzymic synthesis of fucosylated substrates, (2) x-ray crystallography and NMR spectroscopy, (3) synthesis of sLe a and sLe x determinants as potential tools for treatment of inflammatory diseases or the prevention of metastases.
For these purposes, we have undertaken the synthesis and characterization of a truncated human Fuc-TIII enzyme by the methylotrophic yeast Pichia pastoris, a cell which produces 30% of total soluble protein as alcohol oxidase when it uses methanol as a carbon source (Ellis et al., 1985; Cregg et al., 1993) . Truncated Fuc-TIII synthesis is under the control of this methanol inducible alcohol oxidase (AOX1) promoter and the yeast secretes the protein through the secretory pathway using the pre-pro α-mating factor signal sequence.
Results

Construction of a pPIC9 recombinant vector containing a truncated human FUT3 coding sequence
A 1125 bp coding sequence located between the two engineered EcoRI and XbaI sites of pcDNAI containing FUT3 gene and corresponding to the full length Fuc-TIII peptidic sequence, was transferred to the EcoRI and AvrII sites of pPIC9 polylinker, leading to the pPIC9[FUT3] vector. Then, a 1002 pb fragment located between the AvrII site downstream from the transmembrane domain of FUT3 gene and the NotI site of pPIC9 [FUT3] was cloned into the pPIC9 vector ( Figure 1A ). The final construct contained the human FUT3 coding sequence lacking the 132 bp corresponding to cytosolic and transmembrane domains and to the N-ter of the stem region (44 amino acids). This construct was located downstream from the α-factor signal sequence of the yeast Saccharomyces cerevisiae and was under the control of the yeast alcohol oxidase promoter (5′AOX1, Figure 1B ). The resulting pPIC9[FUT3t] plasmid was linearized by digestion with SalI and transferred by electroporation into the GS115 Pichia pastoris (his4) yeast strain ( Figure 1C) . Consequently, the truncated protein, N-extended by four extra amino acids, synthesized along the secretory pathway will be released after two specific proteolytic cleavages ( Figure 1A) .
Expression of the truncated Fuc-TIII enzyme
Stable transformants were selected for histidine prototrophy by plating on a dextrose-YNB medium without histidine. Plasmid integration was analyzed on 10 His + integrants, presenting a high growth rate, by PCR using 5′ and 3′AOX1 primers corresponding to flanking sequences of the native AOX1 gene (Figure 2 ). Eight positive integrants provided the expected 1498 bp PCR product. Clones 10 and 20 which lack the 1498 bp fragment appeared as spontaneous revertants. Fig. 1 . Construction of the Fuc-TIII expression vector and genomic integration. Relevant cloning sites AvrII and NotI were located downstream from the α-factor signal sequence and upstream from the 3′AOX1 transcription termination fragment (TT), respectively. (A) Italic codons correspond to the α-factor signal sequence. Boldface codons represent the limits of truncated FUT3 sequence. Shaded protein sequence indicates protease cleavage sites for KEX2 (arrow and *) and STE13 (arrow and ** ) gene products, respectively. The amino-terminus sequence of the recombinant protein is indicated in one letter code boldface characters. Circular form of pPIC9[FUT3t] plasmid (B) was linearized by cleavage to SalI site located in the wild type HIS4 gene. The linear plasmid containing the FUT3t expression cassette (C) was integrated into the mutated his4 locus of the yeast genome, generating one mutant (his4) and one wild-type (HIS4) chimeric sequences. AOX1, Alcohol oxidase gene sequence; 5′AOX1, AOX1 promoter region; 3′AOX1 (TT), Transcription termination fragment; HIS4, wild type gene encoding histidinol dehydrogenase; S, α-factor signal sequence of S.cerevisiae. The expression levels of functional Fuc-TIII enzyme in 1% methanol-induced recombinant GS115 cells (see Materials and methods), were significantly different from one clone to another as revealed by fucose transfer to the type 1 substrate (Table I) . Clone 25 that showed the highest expression level was selected for further characterizations. Fuc-TIII enzyme remained at first enclosed in the cell and its release in culture broth occurred 38 h after the beginning of methanol induction. In order to better understand the intracellular processing of the truncated human Fuc-TIII enzyme, we determined its subcellular distribution. As expected, the truncated Fuc-TIII activity was mainly located (85.5%) into the cytosol (probably in exocytosis vesicles) and the periplasmic space (Table II) . The transiently resident activity found in the Golgi apparatus was restricted to 5.6%. Crude extract corresponds to cells contained in 100 ml of culture broth (48 h). Cell pellet was twice washed and disrupted with glass beads. Subcellular fractions were obtained as described in the Materials and methods. Assays (60 µl) contained 24 µl of each fraction, 0.1 mM type 1 acceptor substrate, 2.8 µM GDP-[ 14 C]fucose (100,000 c.p.m.), and were incubated for 1 h at 37_C. 
Production by high density fed-batch fermentation and purification of enzyme
An overnight culture (200 ml) in 1% glycerol as a carbon source was carried out in order to inoculate one liter (A 600 = 0.86) of fresh medium without glycerol. Fed-batch production of the enzyme was initiated by 1% methanol. Methanol concentration, culture volume, temperature, agitation rate, and pH were maintained during 169 h. Activity of Fuc-TIII enzyme, present in the culture medium or enclosed in cells, was measured all along the experiment ( Figure 3 ). Whereas the Fuc-TIII activity increased in whole cells during the first 30 h, it was undetectable in supernatant ( Figure 3 ). Then, supernatant Fuc-TIII activity rapidly increased as cell growth slowed down. At the end of the process (169 h), the whole cell-enclosed Fuc-TIII enzyme represented only 0.1% of the total enzyme activity.
SDS-PAGE of supernatant proteins, revealed a major band at 43 kDa representing about 10% of the whole. This protein was Since the total supernatant proteins obtained in a 1 l fed-batch process was approximately 300 mg, the amount of recombinant enzyme was close to 30 mg. To purify the Fuc-TIII enzyme (inhibited at about 70% by antifoam added into the fermentor), we performed an affinity chromatography of supernatant proteins on GDP-Fractogel as described in Materials and methods. Based on this experiment, we determined that the overall enzyme concentration was 11.3 U per liter with an approximate specific activity of 400 mU/mg protein. The purified protein was clearly detected by silver staining and Western blotting as a 43 kDa band (Figure 4, lanes 3 and 4) .
Substrate specificity of soluble enzyme and cell-enclosed enzyme as reusable catalyst
In order to assess in vitro substrate acceptor pattern of the truncated enzyme, activity was determined with various type 1, type 2, Le a , and Le x acceptors, and compared to that of full length enzyme produced in COS7 cells transfected with the human FUT3 gene (Table III) . The analysis demonstrated that the truncated enzyme synthesized very efficiently Le b and at lower rate Le a , Galα1,3-Le a , and sLe a . Similar results were obtained for the Fuc-TIII enzyme produced in COS7 cells. Under our conditions, type 2 acceptors were very poor substrates for Fuc-TIII enzyme. No transfer activity was detected with three of the four type 2 acceptors tested; H-type 2 accounted for 3-4% of the activity measured with type 1 acceptor (Table III) . However, it has been shown (Lubineau et al., 1998 ) that fucose transfer on type 2 acceptors occurs at higher acceptor concentrations (5, 10, 20 mM). On the other hand, a very low α(1,2) fucose transfer activity (3 or 4%) was measured with Le a as a substrate acceptor, whatever the recombinant Fuc-TIII enzyme used (data not shown). Galβ1-3GlcNAc-R (3) 100 100
Fucα1-2Galβ1-3GlcNAc-R (5) 270 230
Type 2
The reference value (100) By analyzing the rate of formation of fucosylated products at various concentrations of the type 1 acceptors, the K m and V max values were determined (Table IV) . The affinity of the truncated Fuc-TIII enzyme for type 1 precursor was 4-, 2.5-, and 2-fold lower than for H-type 1, Galα1-3-type 1, and sialyl-type 1, respectively. The V max for the former substrate was 21 times and 15 times lower than with H-type 1 and Galα1-3-type 1, respectively, and of the same magnitude for the sialyl-type 1.
To test the ability of cell-enclosed Fuc-TIII enzyme to stand up to successive assay and storage periods, repeated freezing and thawing cycles were carried out using 2·10 8 and 5·10 7 cells, respectively ( Figure 5) . A steady decrease (about 5%) of Fuc-TIII activity occurred when assays were performed on 5·10 7 cells during 4 h with the type 1 substrate as an acceptor. Using 2·10 8 cells and an incubation time of 1 h, enzyme activity remained stable over 5 cycles with a marked activity increase during the first two cycles (35 and 20%, respectively). 
Discussion
The construction of a truncated form of human α(1,3/4) fucosyltransferase was undertaken with the aim to produce a soluble form of enzyme. This was made by deleting the first 134 nucleotides of the FUT3 coding sequence. This results in a soluble protein deleted of its first 44 amino acids and presenting four N-ter additional amino acids (Tyr-Val-Glu-Phe). Surprisingly, no Fuc-TIII activity is detected in the culture broth before 30 h of induction. Such a phenomenon, already described by Tschopp et al. (1987) for invertase production with reference to pulse-chase experiments, has been attributed to a slow secretion rate by Pichia cells. To substantiate this observation, we show here that the enzyme (85.5% of activity) accumulates in exocytosis vesicles and in the periplasmic space before its release in culture broth (Table II, Figure 3 ). We also show that the cell-enclosed enzyme was firmly trapped inside the cell wall, although substrates and products could be freely exchanged ( Figure 5 ). Furthermore, there is an unexpected increase of enzyme activity during the first two cycles of freezing and thawing suggesting a release of exocytosis vesicle-enclosed enzyme, which compensates for the loss of activity due to the physical treatment and even gives an apparent increase of the enzyme activity ( Figure 5 ). The soluble form of fucosyltransferase accounted for 10% of the whole supernatant proteins so that its purification could be achieved by a single chromatography step using GDP-Fractogel (Figure 4 ). From the difference observed (5 kDa) between the apparent molecular mass of the purified protein (43 kDa) and the unglycosylated polypeptide (38 kDa), it was suggested that the well known two putative glycosylation sites are occupied by oligomannosidic glycans, accounting for about 20 mannose residues.
Just like the enzyme produced by COS7 cells, the truncated enzyme secreted by Pichia cells, showed virtually no or very low activities with type 2 acceptors. Using differently truncated Fuc-TIII enzymes, De Vries et al. (1995) and Costa et al. (1997) obtained similar results, whereas Costache et al. (1997) found 1% and Johnson et al. (1993) 10% of enzyme activity as compared to the type 1 acceptor substrate. This difference might be due to the truncated form of the enzyme secreted by P.pastoris, or the peculiar in vitro assay conditions applied. It should be emphasized that solubilization of membrane-bound glycosyltransferases, after disruption of COS7 cells in the presence of detergents, frequently results in a mixture of proteolytically cleaved and intact forms, which makes difficult the in vitro assessment of the substrate specificity with the native Golgi enzymes. However, when coexpressing the human erythropoietin and Fuc-TIII in BHK cells, Costa et al. (1997) did not detect peripheral fucosylation of the secreted erythropoietin, a result that supports the view that the enzyme acts in vivo as a α(1,4) fucosyltransferase only. Since Colo 205 α(1,3/4) fucosyltransferase can synthesize a Le b motif from a Le a acceptor substrate (Chandrasekaran et al., 1995) , the α(1,2) fucosyltransferase activity of truncated Fuc-TIII enzyme was assayed with Le a and Le x acceptor substrates. Both truncated and full length recombinant enzymes catalyzed, at a very low level, the α(1,2) fucosylation of terminal galactose with Le a as an acceptor. This is not surprising since similar small amounts of A and B oligosaccharide products were found to be made by the opposite B and A enzymes, respectively (reviewed in Watkins et al., 1988) , suggesting that a weak cross-enzyme activity might be a more common than expected feature of glycosyltransferases.
Finally, the heterologous expression of an engineered truncated form of human fucosyltransferase III has been successfully performed (about 30 mg/l culture broth) for the first time by the methylotrophic yeast Pichia pastoris. It presents the same catalytic properties as its full length form. Considering the medical and pharmacological importance of fucosyltransferases, this new heterologous expression system could be useful to provide the amount of protein required for structural studies and chemo-enzymatic synthesis. Moreover these recombinant Pichia pastoris cells have been already used for the fucosylation of a sulfated tetrasaccharide of Lewis x type (Lubineau et al., 1998) .
Materials and methods
Materials
Plasmid pPIC9 and P. pastoris strain GS115 (his4) were obtained from InVitrogen (San Diego, CA). Type 1 and Galα1-3-type 1-O-octyl were synthesized according to Augé et al. (1976) and to Lubineau et al., (1996) , respectively. Dr. M. Palcic (Alberta Research Council, Edmonton, Canada) kindly provided the 8-methoxycarbonyloctyl type 2. H-Type 1-sp-biotin, H-type 2-sp-biotin, Le a -sp-biotin, Le x -sp-biotin, sialyl-type 1-O-sp-biotin, and sialyl-type 2-O-sp-biotin were purchased from Synthesome (Russia). GDP-Fractogel was a generous gift of Dr. H. Conradt (Protein Glycosylation, Braunschweig, Germany). Enzymes for DNA manipulations were obtained from Boehringer Mannheim Biochemicals (Mannheim, Germany) or New England Biolabs (Beverly, MA). Yeast extract, bactopeptone, and yeast nitrogen base were from Difco Laboratories (Detroit, MI). All other reagents were of molecular biology grade.
Transfection and expression of the FUT3 gene in COS7 cells
DNA sequence corresponding to the FUT3 gene (1125 bp) was obtained by amplification of the FUT3 cDNA (Mollicone et al., 1994) . The amplified fragment containing the two engineered sites EcoRI/XbaI was digested with the respective enzymes and cloned between the EcoRI/XbaI restriction sites of the mammalian expression vector pcDNAI (Invitrogen) to give the pFUT3 vector. COS7 cells were transfected with DEAE-dextran (Davis et al., 1986) and harvested after a 48 h expression period (Weston et al., 1992) .
Cloning of the truncated FUT3 gene into the pPIC9 expression vector
Routine cloning experiments were performed as described previously (Ausubel et al.,1989; Sambrook et al., 1989) .
The pPIC9 The Pichia strain GS115 (his4) was transformed by electroporation (1500 V, 25 µF and 200½, Bio-Rad Gene Pulser) with 10 µg of SalI linearized pPIC9[FUT3t] vector and plated onto a histidine devoid RDB medium (1 M sorbitol, 1% (w/v) dextrose, 1.34% (w/v) YNB, 4·10 -5 % (w/v) biotin, 5·10 -3% (w/v) of each l-glutamic acid, l-methionine, l-lysine, l-leucine, and l-isoleucine). The integration at the expected locus was checked by replica plating on MM and MD agar (1.34% (w/v) YNB, 4·10 -5% (w/v) biotin and 0.5% (v/v) methanol or 1% (w/v) dextrose). Colonies were allowed to grow for 2 days at 30_C. Clones that grew rapidly on MM medium were picked for further investigation.
PCR analysis of Pichia integrants
Yeast genomic DNA was extracted according to Ausubel et al. (1989) , from selected clones grown overnight in 5 ml YPD medium (1% (w/v) yeast extract, 2% (w/v) bactopeptone, and 2% (w/v) dextrose) at 30_C.
PCR was performed in a mixture containing 50 mM KCl, 10 mM Tris-HCl (pH 9), 1 mM MgCl 2 , 100 µM of each dNTP, 1 µl of genomic DNA (about 100 ng), 10 pmol of PCR primers (5′AOX1 : 5′-GACTGGTTCCAATTGACAAGC-3′; 3′AOX1 : 5′-GCAAATGGCATTCTGACATCC-3′) and 1.25 U of Taq DNA polymerase (Promega) in a total volume of 25 µl. After heating at 94_C for 3 min, 25 cycles were performed (denaturation at 94_C for 1 min, annealing at 55_C for 1 min, and extension at 72_C for 1 min). PCR products were analyzed on 1% (w/v) agarose gel electrophoresis.
Subcellular localization of Fuc-TIII activity
Subcellular fractionation of yeast cells was made as described by Gallet et al. (1995) . Cells (48 h) were harvested by centrifugation (3000 × g for 5 min and 4_C) and washed in cold distilled water and then by mannitol/Tris buffer (0.6 M mannitol, 10 mM Tris-HCl pH 7.4). Cells were suspended in the same buffer and broken with acid-washed glass beads (6 × 30 s at 4_C). The homogenate was centrifuged at 1000 × g for 5 min and 4_C to pellet glass beads and unbroken cells. The resulting supernatant was centrifuged at 3600 × g for 5 min and 4_C to pellet cell walls. The nuclear fraction was obtained by centrifugation at 5000 × g for 5 min at 4_C while mitochondria were pelleted at 25,000 × g for 10 min and 4_C. The microsomal fraction was then sedimented at 120,000 × g for 1 h and 4_C. The resulting supernatant represented the cytosolic and periplasmic space fractions.
Pichia expression studies
Yeast preculture was made in 10 ml of MG medium (1.34% (w/v) yeast nitrogen base, 4·10 -5% (w/v) biotin, 1% (v/v) glycerol) for 12 h at 30_C to A 60 0 = 4. Cells harvested by centrifugation (3000 × g for 5 min and 20_C) and washed with 10 ml of 1.34% (w/v) YNB, were then mixed to 10 ml of MM medium (A 600 = 1). Induction was carried out for 48 h with 1% (v/v) methanol under vigorous shaking at 30_C. Cells were harvested by centrifugation (3000 × g for 5 min and 4_C), washed with cold water, and suspended in 2.5 mM sodium cacodylate, pH 6.5. Cell breakage was made as described above. The protein content was determined by the Bradford assay (Bio-Rad) using bovine serum albumin as a standard (Bradford, 1976) .
Fermentation
The inoculum for enzyme production, was obtained from 200 ml of overnight MG medium culture (A 600 = 10). Cells were harvested by centrifugation 3000 × g for 10 min and 20_C, washed by 50 ml of 0.67% (w/v) YNB and diluted to A 600 = 0.86 in the growth medium composed of 0.67% (w/v) YNB and 4·10 -5 % (w/v) biotin. During the 169 h induction, pH was maintained at 6.0 with 28% (v/v) ammonium hydroxide and temperature to 30_C. Methanol was continually added at a flow of 5 g/l·h. Agitation speed was 600 r.p.m., and air flow was 2.5 l per min. A supplement of YNB/biotine 5× was added to account for water evaporation. To prevent extensive foam formation, antifoam A (Sigma) was added. At the end (169 h), the culture was harvested by centrifugation 3000 × g for 10 min and 4_C. Supernatant and cells were recovered and stored at -20_C.
SDS-PAGE and Western blot analysis
Culture supernatant (20 µl) was analyzed by SDS-PAGE using a 12.5% acrylamide Tris-Tricine gel (SchSgger and Von Jagow, 1987) . Proteins were visualized by silver staining (Blum et al., 1987) . The amount of Fuc-TIII enzyme was determined by densitometry analysis (Vilbert-Lourmat, BioProfil software). Proteins were transferred onto nitrocellulose membrane (Schleicher & Schuell, Germany) which was blocked overnight at 4_C by phosphate-buffered saline containing 1% (v/v) Tween 20 and 5% (w/v) bovine serum albumin (PBS-T-BSA). After three washings in PBS-T, the membrane was incubated for 1 h at 20_C with a rabbit anti-Fuc-TIII antibody in PBS-T-BSA buffer at 1:500 dilution. Donkey anti-rabbit immunoglobulin coupled to horseradish peroxidase (Amersham, England), was used at 1:1000 dilution. The blots were developed according to the ECL detection Kit (Amersham, England).
Protein purification
Fifty milliliters of the culture broth were centrifuged for 20 min at 18,000 × g and 4_C and applied onto a 2 ml GDP-Fractogel column equilibrated with 20 mM Mes-KOH, pH 6.8, containing 0.02% (w/v) NaN 3 and 1 mM dithiothreitol at a flow rate of 0.8 ml·min -1 at room temperature. The column was washed by 20 mM Mes-KOH buffer, pH 6.8 (19 ml), containing 50 mM NaCl, 0.02% (w/v) NaN 3 , and 30% (v/v) glycerol at a flow rate of 0.8 ml·min -1 and the same buffer (19 ml) containing 500 mM NaCl at the same flow rate. The enzyme was eluted from the column by the same buffer (14 ml) containing 1.5 M NaCl at a flow rate of 0.4 ml·min -1 . The eluted fraction was stored at -20_C or precipitated by 1 volume of acetone/β-mercaptoethanol 0.7% (v/v) at -20_C for 24 h. After centrifugation for 1 h at 100,000 × g and 4_C, the protein pellet was suspended in 30 µl of elution buffer and analyzed by SDS-PAGE and immunoblotting.
Fucosyltransferase assay
Fucosyltransferase assays were performed according to Oulmouden et al. (1997) . The enzyme activity with type 1, type 2, Le a , or Le x glycoside acceptors was tested at 37_C in 60 µl of the following reaction mixture: 25 mM sodium cacodylate, pH 6.5, 5 mM ATP, 20 mM MnCl 2 , 10 mM α-l-fucose, 2.8 µM GDP-[ 14 C]fucose (168 pmol/100,000 c.p.m.). Acceptors were used at 0.1 mM. The reaction was initiated by addition of 34 µl of culture broth or 10 8 whole yeast cells or 50 µg of COS7 cell proteins. After 1 h of incubation, the reaction was stopped by addition of 3 ml of cold water, then centrifuged at 3000 x g for 5 min and 20_C. The supernatant was applied onto Sep-Pak C18 cartridges, which were washed with 10 ml of water. The products were eluted with 10 ml methanol. The incorporation of [ 14 C]fucose was determined by liquid scintillation counting.
Enzyme kinetics was performed in reaction mixtures as described above except that the concentrations of the type 1, H-type 1, Galα1-3-type 1, and sialyl-type 1 acceptors varied from 0 to 0.1 mM and GDP-[ 14 C]fucose was 7 µM. The apparent kinetic parameters were determined from Michaelis-Menten curves fit to the experimental data using the least square method.
After GDP-Fractogel purification, the enzyme activity was measured in the presence of type 1 acceptor as described above, except that 0.2 mM (12.12 nmol/100,000 c.p.m.) GDP-Fucose was used. One unit of enzyme activity was defined as the amount of enzyme catalyzing the transfer of 1 µmol of fucose/min to the octyl-glycoside type 1 substrate.
To determine enzyme stability, 48 h methanol-induced Pichia cells (1 ml) were pelleted by centrifugation at 3000 × g for 5 min and 4_C, washed with cold distilled water, and suspended into 1 ml of 25 mM sodium cacodylate, pH 6.5. Aliquots of 2·10 8 and 5·10 7 cells were used to determine the Fuc-TIII activity. The reaction mixture was as described above, with 0.1 mM type 1 acceptor and 2.8 µM GDP-[ 14 C]fucose. The incubation times were 1 and 4 h for 2·10 8 and 5·10 7 cells, respectively. The reaction was stopped with 3 ml of cold distilled water. The suspension was centrifuged at 3000 × g for 5 min and 4_C to pellet cells which were immediately stored at -20_C.
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